Skip to main
ARDT

ARDT Stock Forecast & Price Target

ARDT Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 36%
Hold 27%
Sell 9%
Strong Sell 0%

Bulls say

Ardent Health is a strong player in the healthcare industry, with a dominant market share in attractive mid-sized urban markets across six states. Their focus on people and investments in services and technologies positions them for continued growth and success. Additionally, their joint venture strategy with leading academic and not-for-profit health systems provides an efficient way to expand and improve their network. With a proven track record of profitability and potential for future growth through in-market expansion and M&A, Ardent presents a compelling investment opportunity.

Bears say

Ardent Health is facing significant risks to its profitability and growth potential due to factors such as government reimbursement cuts, potential labor shortages and challenges in executing M&A deals. Additionally, the company is exposed to election and healthcare policy risks, which could impact its financial performance. These risks, along with soft guidance for the next quarter and an uncertain outlook for its Healthcare Insurance Exchanges (HIX) business, contribute to a negative outlook for the stock despite maintained revenue and EBITDA guidance for 2026. Investors should closely monitor the company's operational and financial performance, as well as any changes in healthcare policies, to make informed decisions about investing in Ardent Health.

ARDT has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 36% recommend Buy, 27% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ardent Health Partners LLC and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ardent Health Partners LLC (ARDT) Forecast

Analysts have given ARDT a Buy based on their latest research and market trends.

According to 11 analysts, ARDT has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.59, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.59, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ardent Health Partners LLC (ARDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.